Phosphoric Acid

Phosphoric Acid

SCHEMBL5907878

O=P([O-])(O)O.O=P([O-])(O)O.[K+].[Na+]

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC34A1 Q06495 1/20 0.90
▸ KDM4E B2RXH2 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ CA4 P22748 4/20 0.39
▸ CA2 P00918 1/20 0.39
▸ FAHD1 Q6P587 1/20 0.39
▸ CA1 P00915 2/20 0.37
▸ CA5A P35218 2/20 0.37
▸ CA5B Q9Y2D0 2/20 0.37
▸ BLM P54132 2/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ FDPS P14324 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ MEN1 O00255 1/20 0.31
▸ LDHA P00338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL5293558 1.00 SLC34A1 (0.90) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL10787868 1.00 SLC34A1 (0.90) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL5745536 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL18832766 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL5608739 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL532270 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL2128094 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL4332135 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL5745541 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA
Phosphoric Acid SCHEMBL6310117 0.95 SLC34A1 (0.82) SLC34A1KDM4EKMT2ACYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111194304-B Preparation method of bridged ring compound 宜昌东阳光长江药业股份有限公司 2022-09-27 — — CN claimed
WO-2022135331-A1 STABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING KUDING SAPONIN COMPOUND 上海凯屹医药科技有限公司 2022-06-30 — — WO claimed
CN-113045774-B Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof 江汉大学 2022-05-13 — — CN claimed
CN-114031791-A Multi-response color-changing hydrogel and preparation method and application thereof 长春工业大学 2022-02-11 — — CN claimed
CN-113045774-A Double-network composite hydrogel or hydrogel ball containing nano-silver and preparation method and application thereof 江汉大学 2021-06-29 — — CN claimed
CN-108288695-B Zinc-based secondary battery negative electrode material and preparation method thereof 中南大学 2020-09-01 — — CN claimed
CN-111194304-A Preparation method of bridged ring compound 广东东阳光药业有限公司 2020-05-22 — — CN claimed
WO-2019201279-A1 METHOD FOR PREPARING BRIDGE RING COMPOUND 广东东阳光药业有限公司 2019-10-24 — — WO claimed
CN-106400085-B A kind of aluminium and aluminium alloy anode oxide film post-processing hole sealing agent and post-processing approach 武汉风帆电化科技股份有限公司 2019-05-14 — — CN claimed
CN-109354601-A The extracting method of selenoprotein in a kind of pear fruit 淮阴工学院 2019-02-19 — — CN claimed
CN-108288695-A A kind of zinc-based secondary battery cathode material and preparation method thereof 中南大学 2018-07-17 — — CN claimed
CN-106400085-A Hole sealing agent and method for aluminum and aluminum alloy anode oxide film aftertreatment 武汉风帆电化科技股份有限公司 2017-02-15 — — CN claimed
CN-104436289-B Paper diaper containing formaldehyde scavenger 天津市中科健新材料技术有限公司 2017-01-18 — — CN claimed
CN-104161847-B A kind of quality determining method of the Chinese medicine composition treating diabetic retinopathy 北京汉典制药有限公司 2016-08-24 — — CN claimed
US-20160019992-A1 BINDER AND THE USE THEREOF FOR CONDITIONING WASTE CONTAINING ALUMINIUM METAL COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2016-01-21 — — US claimed
CN-101881750-A Microchip detector of content of arteannuin in Artemisia apiacea and method thereof UNIV CHONGQING 2010-11-10 — — CN claimed
EP-0878470-A1 Process for the preparation of epoxides from olefins Linde Aktiengesellschaft (DE) 1998-11-18 — — EP claimed
EP-0231816-B1 PHARMACEUTICAL PREPARATIONS FOR THE STABILIZATION OF INTERFERON ALPHA Dr. Karl Thomae GmbH (DE) 1991-05-29 — — EP claimed
CN-116924928-A Preparation method of aliskiren intermediate 江苏阿尔法药业股份有限公司 2023-10-24 — — CN disclosed
EP-0878470-A1 Process for the preparation of epoxides from olefins Linde Aktiengesellschaft (DE) 1998-11-18 — — EP disclosed
Send feedback